Advertisement
Research ArticleEndocrine and Diabetes

Preclinical Efficacy and Safety of the Novel Anti-diabetic, Anti-obesity MetAP2 Inhibitor, ZGN-1061

Bryan F. Burkey, Niel C. Hoglen, Philip Inskeep, Margaret Wyman, Thomas E. Hughes and James E. Vath
Journal of Pharmacology and Experimental Therapeutics February 28, 2018, jpet.117.246272; DOI: https://doi.org/10.1124/jpet.117.246272

Article Information

jpet.117.246272
DOI 
https://doi.org/10.1124/jpet.117.246272
PubMed 
29491038
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online February 28, 2018.

Article Versions

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Bryan F. Burkey1,*,
  2. Niel C. Hoglen1,
  3. Philip Inskeep2,
  4. Margaret Wyman1,
  5. Thomas E. Hughes1, and
  6. James E. Vath1
  1. 1 Zafgen, Inc.;
  2. 2 Inskeep DMPK, LLC
  1. ↵*Address correspondence to: bburkey{at}zafgen.com

Statistics from Altmetric.com

Article usage

Article usage: February 2018 to September 2024

AbstractFullPdf
Feb 2018167017
Mar 201859113207
Apr 20182944751
May 20181863634
Jun 20182042925
Jul 2018881521
Aug 2018852035
Sep 201875813
Oct 20181322926
Nov 2018882013
Dec 201844513
Jan 20191191925
Feb 2019671413
Mar 2019802023
Apr 2019105445
May 2019157530
Jun 2019435730
Jul 2019485834
Aug 2019536427
Sep 201994726
Oct 2019216829
Nov 2019148636
Dec 2019203623
Jan 202063925
Feb 202034031
Mar 202043526
Apr 202093217
May 2020133521
Jun 202083211
Jul 202033414
Aug 202041510
Sep 2020112825
Oct 2020173313
Nov 202043321
Dec 202022811
Jan 202132915
Feb 2021102826
Mar 2021155021
Apr 2021183626
May 202182214
Jun 202133011
Jul 202172625
Aug 202152113
Sep 2021122827
Oct 202152926
Nov 202123132
Dec 202114312
Jan 202252229
Feb 202241714
Mar 202296122
Apr 202232416
May 202222723
Jun 202262310
Jul 202252621
Aug 202232315
Sep 202262826
Oct 202262411
Nov 202253031
Dec 20224238
Jan 20237216
Feb 20236138
Mar 202392418
Apr 202312514
May 202352827
Jun 202321210
Jul 202311827
Aug 20234913
Sep 202311613
Oct 202353118
Nov 20231212522
Dec 202342612
Jan 20244236
Feb 20245208
Mar 202443013
Apr 20249056
May 20242827
Jun 20246835
Jul 20244735
Aug 20245652
Sep 20242300

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleEndocrine and Diabetes

Preclinical Efficacy and Safety of the Novel Anti-diabetic, Anti-obesity MetAP2 Inhibitor, ZGN-1061

Bryan F. Burkey, Niel C. Hoglen, Philip Inskeep, Margaret Wyman, Thomas E. Hughes and James E. Vath
Journal of Pharmacology and Experimental Therapeutics February 28, 2018, jpet.117.246272; DOI: https://doi.org/10.1124/jpet.117.246272
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement